0.04Open0.05Pre Close10 Volume111 Open Interest2.50Strike Price43.00Turnover400.82%IV112.50%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1696Delta0.3588Gamma24.00Leverage Ratio-0.0112Theta0.0000Rho4.07Eff Leverage0.0004Vega
Cumberland Pharmaceuticals Stock Discussion
Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy
$SNDL Inc (SNDL.US)$
$Cumberland Pharmaceuticals (CPIX.US)$
$Sonoma Pharmaceuticals (SNOA.US)$
$Ispire Technology (ISPR.US)$
$Veru Inc (VERU.US)$
$Greenlane (GNLN.US)$
$OrganiGram (OGI.US)$
$Cronos Group (CRON.US)$
$GrowGeneration (GRWG.US)$